# GSK plc: Form 20-F for the period ended Dec 31, 2018

- Company: [GSK plc](/companies/gsk.md) (CIK 1131399)
- Form: 20-F
- Filed: 2019-03-15
- Accepted by EDGAR: Mar 15, 2019, 20:21 ET
- Period: 2018-12-31
- Accession: 0001193125-19-076716
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2018-01-01 to 2018-12-31 | GBP 30.82bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2018-01-01 to 2018-12-31 | GBP 10.24bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2018-01-01 to 2018-12-31 | GBP 20.58bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | GBP 5.48bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | GBP 754.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | GBP 3.62bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | GBP 0.73 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | GBP 0.74 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | GBP 8.42bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-01-01 to 2018-12-31 | GBP 1.34bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2018-12-31 | GBP 3.87bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2018-12-31 | GBP 16.93bn | ifrs-full:CurrentAssets |
| Total assets | at 2018-12-31 | GBP 58.07bn | ifrs-full:Assets |
| Current liabilities | at 2018-12-31 | GBP 22.49bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2018-12-31 | GBP 54.39bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2018-12-31 | GBP 4.36bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2018-12-31 | 5,379,067,624 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131399/000119312519076716/d601746d20f.htm

Filed Mar 15, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-076716. Last ingested by Listed: Nov 6, 2026, 12:49 ET. No prices; not investment advice.